Improvement Upon a Multi-Residue Method for Nitrosamine Analysis in Losartan Drug Product Using an Enhanced LC/MS/MS System

Application Note Pharma/Biopharma Determination of Nitrosamine Impurities Using the Agilent 6475 Triple Quadrupole LC/MS System Authors Linfeng Wu and Lee Bertram Agilent Technologies, Inc. Santa Clara, CA, U.S. Shan-An Chan Agilent Technologies, Inc. Taiwan Abstract Nitrosamine impurities are by-products that…

Application Note Determination of Nitrosamine Impurities Using the Agilent 6495D Triple Quadrupole LC/MS System Authors Abstract Lee Bertram and Linfeng Wu Agilent Technologies, Inc. Nitrosamine impurities are byproducts produced in trace amounts during the manufacture of pharmaceutical drugs. These impurities…

Application Note Biopharma Quantitative Analysis of Nitrosamine Impurities in Synthetic Oligonucleotides Using the Agilent 6495D triple quadrupole LC/MS system Author Abstract Yulan Bian Agilent Technologies, Inc. Nitrosamines are genotoxic impurities of significant concern in pharmaceuticals due to their carcinogenic potential.…

Application Note Pharmaceutical Determination of Nitrosamines in Active Pharmaceutical Ingredients High flexibility and performance at lowest cost using the Agilent 1260 Infinity II Prime LC with the Agilent Ultivo LC/TQ for LC/MS analysis Author Edgar Naegele Agilent Technologies, Inc. Abstract…